$4.4 M Diabetes Patch Brand: Hidden Gem or Hidden Trap?
whatshot 21 snips
Nov 7, 2025
Dive into a potential goldmine with a $4.4M e-commerce business specializing in diabetes patch accessories. Assess the impressive 41% net margin and explore the world of continuous glucose monitors. The hosts analyze the product's market positioning, investigate licensing opportunities, and discuss strategies for U.S. expansion through influencer marketing. They also tackle risks like compliance challenges and financing hurdles, making for an engaging debate on whether this opportunity is a hidden gem or a risky venture.
46:35
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
Numbers Convert From AUD, Changing The Deal
The listing shows ~US$3.5M revenue and US$1.46M cash flow, but those numbers are converted from AUD which changes buyer dynamics.
The Australian base and currency conversion likely explain the lower multiple and financing complexity.
insights INSIGHT
Margins Appear 'Loaded' By Marketplace Fees
The hosts flag a likely 'loaded' gross margin where marketplace fees sit above gross margin, inflating net margin appearance.
That implies product unit economics are very strong but you must verify fee accounting.
insights INSIGHT
Pharmacy Accounts Give Real Defensibility
Securing two U.S. pharmacy accounts buying ~$789K signals channel-level validation beyond FBA vulnerability.
That retail distribution materially raises defensibility versus being 'just stickers' on Amazon.
Get the Snipd Podcast app to discover more snips from this episode
In this episode of Acquisitions Anonymous, the hosts dig into a $4.4 M e‑commerce business in the diabetes sensor accessory space and debate whether its 41% net margin, Australian base, and licensing opportunity make it a smart buy—or a risky startup in disguise.
Business Listing – https://websiteproperties.com/websites/13755-sticking-with-success-great-business-opportunity-in-the-growing-diabetes-market/
Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.
💰 Sponsored by: Go High Level – The all-in-one sales and marketing platform built for agencies and entrepreneurs. Automate, manage, and grow your business at https://www.gohighlevel.com
Capital Pad – A platform connecting accredited investors with vetted small business acquisition deals. Discover exclusive opportunities at https://capitalpad.com
The team explores a listing for a home‑based Australian business selling branded adhesive patches for continuous glucose monitors (CGMs) — the listing claims approximately US $3.5 M in trailing 12‑month revenue (converted from AUD) and US $1.46 M in cash‑flow (~41 % net margin). The business model includes Amazon FBA plus a couple of major U.S. pharmacy accounts, with the owner working ~10 hours/week.
Key Highlights: - Asking price ~US $4.4 M, trailing cash‑flow US $1.46 M (≈41 % net margin) - Business based in Australia, selling (via Amazon + pharmacies) consumable patches for CGMs — a growing diabetes adjacent market - Opportunity for U.S. expansion + licensing of characters/brands to build a moat - Risks: Australian entity, potential Amazon seller‑migration issues, unclear SBA financing, low barrier to entry in consumables - Strategic path: Use Aussie cash‑flow to buy and build U.S. subsidiary, invest heavily in influencer / TikTok, build brand/licensing to protect margin